Eman Hassan (E Hassan)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Emergency Department

Pulmonary Embolism

Clinical Practice

End Stage Renal Disease

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Pediatric blood & cancer

Indian journal of pediatrics

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Eman Hassan, Jayashree Motwani
Single centre experience of the use of emicizumab in previously untreated and minimally treated patients under 18 months of age. Pediatric blood & cancer 71 (6) (2024)
Eman Hassan, Jayashree Motwani
Single centre experience of the use of emicizumab in previously untreated and minimally treated patients under 18 months of age. Pediatric blood & cancer 71 (6) (2024)
Eman Hassan, Jayashree Motwani
Single centre experience of the use of emicizumab in previously untreated and minimally treated patients under 18 months of age. Pediatric blood & cancer (2024)
Eman Hassan, Phillip Lindsay Ross Nicolson
Challenging situations in patients with cancer-associated thrombosis-Further clarification required in the British Society for Haematology guidelines. British journal of haematology (2024)
Eman Hassan, Jonathan Lancashire, Jayashree Motwani
Emicizumab in previously untreated and minimally treated infants. Haemophilia : the official journal of the World Federation of Hemophilia 28 (2) (2022)
Eman Hassan, Jayashree Motwani
Breakthrough bleeding episodes in pediatric severe hemophilia a patients with and without inhibitors receiving emicizumab prophylaxis: a single-center retrospective review. Pediatric hematology and oncology 39 (5) (2022)
Eman Hassan, Jonathan Lancashire, Jayashree Motwani
Patients on emicizumab prophylaxis with previously tolerized inhibitors: Is there a risk of inhibitors recurrence? Haemophilia : the official journal of the World Federation of Hemophilia (2021)
Eman Hassan, Lancashire Jonathan, Motwani Jayashree
Real-world experience on the tolerability and safety of emicizumab prophylaxis in paediatric patients with severe haemophilia A with and without FVIII inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia 27 (6) (2021)
Eman Hassan, Jayashree Motwani
Management and outcomes of paediatric patients on emicizumab prophylaxis undergoing surgical procedures: Experience from a large haemophilia centre in the UK. Haemophilia : the official journal of the World Federation of Hemophilia 27 (5) (2021)
Eman Hassan, Ghadeer Foulath, Mohamed Abdelghany, Ibrahim Sayed, Dina Elkhity, Yasmine El Chazli
Positive Impact of Clinical Audit on Appropriateness of Laboratory Investigations for Glucose-6-Phosphate Dehydrogenase-Deficient Patients in the Emergency Department. Indian journal of pediatrics 88 (9) (2020)